Medicinal Products

Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju

Name Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju
Marketing Authorisation Number HR-H-879693802
Active Substance irinotekanklorid trihidrat
Composition 1 ml koncentrata sadrži 20 mg irinotekanklorid trihidrata, što odgovara 17,33 mg irinotekana
Pharmaceutical Form koncentrat za otopinu za infuziju
Manufacturer Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska
Marketing Authorisation Holder Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska
Marketing Authorisation Date 11.06.2021
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/108
Registration Number 381-12-01/154-21-03
Prescription Medicinal product subject to medical prescription
Type of prescription ograničeni recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01CE02
Marketing status stavljeno u promet
Shortage status nema nestašice
SmPC download
PL download
Public Assessment Report download

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o neželjenim učincima lijekova koji sadrže irinotekanklorid trihidrat u bolesnika sa smanjenom aktivnošću enzima UGT1A1 14.04.2022 Pliva Hrvatska d.o.o., PharmaS d.o.o., Fresenius Kabi d.o.o.
Back